Results 191 to 200 of about 214,767 (219)

Comparative Analysis of Vascular Endothelial Growth Factor Receptors on Retinal and Aortic Vascular Endothelial Cells

Diabetes, 1995
Ischemic eye disease often results in ocular neovascularization, presumably due to the elaboration of growth factors. Diabetic retinopathy is a classic example in which dramatic retinal neovascularization arises after ischemic retinal damage. The characterization of vascular endothelial growth factor (VEGF) as an angiogenic molecule whose expression is
H, Thieme, L P, Aiello, H, Takagi, N, Ferrara, G L, King   +4 more
openaire   +2 more sources

Vascular Endothelial Growth Factor (VEGF) Receptors

1995
Abstract Two tyrosine kinases have been recently identified as putative VEGF receptors (deVries et al. 1992; Terman et al. 1992a). The flt-1 (fms-like-tyrosine kinase; Shibuya et al. 1990) and KOR (kinase domain region; Terman et al. 1991) proteins have been shown to bind VEGF with high affinity.
J E Park, N Ferrara
openaire   +1 more source

Vascular Endothelial Growth Factor Receptors in Vascular Development and Hematopoiesis

2001
Abstract The development of the vascular and hematopoietic systems of the vertebrate embryo occurs during early ontogeny and requires a variety of control mechanisms: those that specify mesodermal cells to form the lineage constituents, and those that control their proliferation and their coalescence to form a primitive vascular network.
Kari Alitalo, Yuji Gunji, Riitta Alitalo,, Anne Eichmann   +3 more
openaire   +1 more source

Inhibitors of Vascular Endothelial Growth Factor Receptor

2017
Angiogenesis-targeting agents, predominantly inhibitors of vascular endothelial growth factor and its receptors, have become a mainstay in oncology practice over the last decade. The approved drugs, which include two antibodies and seven small molecule inhibitors, represent strong validation for the field of anti-angiogenesis in the treatment of cancer.
openaire   +1 more source

A receptor for vascular endothelial growth factor that stimulates endothelial apoptosis.

Cancer research, 2002
Vascular endothelial growth factor (VEGF) is a dimeric angiogenic factor that is overexpressed by many tumors and stimulates tumor angiogenesis. VEGF initiates signaling by dimerizing the receptors VEGFR-1 and VEGFR-2. The Fas receptor stimulates apoptosis, and artificial dimerization of the Fas cytoplasmic domain has been shown to induce apoptosis. We
T P, Quinn, S J, Soifer, K, Ramer, L T, Williams, M C, Nakamura   +4 more
openaire   +1 more source

Vascular Endothelial Growth Factors and Receptors

2010
Anna Dimberg, Charlotte Rolny, Laurens A. van Meeteren, Lena Claesson-Welsh   +3 more
openaire   +1 more source

Vascular endothelial growth factors and angiogenesis in eye disease

Progress in Retinal and Eye Research, 2003
Reinier O Schlingemann, C J F Van Noorden   +1 more
exaly  

Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells

Journal of Experimental Medicine, 2001
Sérgio Dias, Beate Heissig, Neil R Hackett   +2 more
exaly  

Mutation in Vascular Endothelial Growth Factor-C, a Ligand for Vascular Endothelial Growth Factor Receptor-3, Is Associated With Autosomal Dominant Milroy-Like Primary Lymphedema

Circulation Research, 2013
Michael A Simpson, Andreas Van Impel, Peter S Mortimer   +2 more
exaly  

Vascular-endothelial-growth-factor-receptor-antagonists

Reactions Weekly, 2022
openaire   +1 more source